Oncacare Revenue and Competitors

London, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Oncacare's estimated annual revenue is currently $3.4M per year.(i)
  • Oncacare's estimated revenue per employee is $201,000

Employee Data

  • Oncacare has 17 Employees.(i)
  • Oncacare grew their employee count by -67% last year.

Oncacare's People

NameTitleEmail/Phone
1
CEO and ChairmanReveal Email/Phone
2
Global Medical DirectorReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
Patient Recruitment and Centricity OfficerReveal Email/Phone
5
Associate Medical DirectorReveal Email/Phone
6
Contracts, ManagerReveal Email/Phone
7
Manager, Legal CounselReveal Email/Phone
8
Patient Recruitment ManagerReveal Email/Phone
9
Data and Regulatory LeadReveal Email/Phone
10
Project AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Oncacare?

Oncacare is passionate about transforming cancer research to advance new treatments. Our strong capabilities enable us to bring together Patients, Sites and Pharma to present a unique solution to the cancer trials industry. The Oncacare global site network provides opportunities for patients and oncologists to advance the development of cancer treatments more quickly and efficiently. Oncacare is a change agent for cancer clinical research.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$3.4M

Revenue (est)

-67%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oncacare News

2022-03-22 - Grand River Hospital relocating its COVID test site as use ...

... for testing eligibility and book an appointment, please visit: https://www.grhosp.on.ca/care/visitors/covid-19/covid-19-testing-clinics.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M17-11%N/A
#2
$1.3M17N/A$8M
#3
$1.5M170%N/A
#4
$1.5M17-41%N/A
#5
$2.2M17-6%N/A